Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Next Gen Pharma India Private Limited, is an unlisted private company incorporated on 31 December, 2004. It is classified as a private limited company and is located in East Delhi, Delhi. It's authorized share capital is INR 5.00 lac and the total paid-up capital is INR 1.40 lac.
Next Gen Pharma India's operating revenue range is INR 1 cr - 100 cr for the financial year ending on 31 March, 2023. It's EBITDA has increased by 29.5% over the previous year. At the same time, it's book networth has increased by 8.52%.
Read more
This action will use 1 of your credits. Are you sure you want to go ahead?
** All rupee values in INR lacs. Based on March 2023 numbers.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
State | Type | Address |
---|
Designation | Name | DIN/PAN | Tenure |
---|---|---|---|
Director | Kanwaldeep Singh Chadha
Shareholder
|
00030566 | 7 years |
Director | Sandeep Om Prakash Juneja | 08062940 | 1 years |
Director | Anuja Chadha
Shareholder
|
08765285 | 4 years |
Director | Jeetendra Shantilalji Jain | 09524592 | 1 years |
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Networth | |||||
Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2023 available in Tofler Pro
Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|
Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
Name | Status | Paid up Capital | Common Directors | Address |
---|---|---|---|---|
CC RESEARCH INDIA PRIVATE LIMITED |
Strike Off
|
1.0 L | 1 | Delhi |
AANVEE HEALTHSCIENCES LLP |
Active
|
1.0 L | 2 | Delhi |
BIONEX VETCARE PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
EMERGERE ANIMAL HEALTH CONSULTING LLP |
Active
|
1.5 L | 1 | Maharashtra |
SHRI PARSHWA ADVISORS (OPC) PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
Read more
The incorporation date of NEXT GEN PHARMA INDIA PRIVATE LIMITED is 31 December, 2004
The authorized share capital of NEXT GEN PHARMA INDIA PRIVATE LIMITED is INR ₹ 5.0 L.
The paid-up capital of NEXT GEN PHARMA INDIA PRIVATE LIMITED is INR ₹ 1.4 L.
The registered address of NEXT GEN PHARMA INDIA PRIVATE LIMITED is Plot no-135, Pocket-C, IFC Gazipur, East Delhi East Delhi East Delhi Delhi - 110096
The CIN number of NEXT GEN PHARMA INDIA PRIVATE LIMITED is U51909DL2004PTC131754.